Etapa 2

114. Yeung, F, Law, WK, Yeh, CH, Westendorf, JJ, Zhang, Y, Wang, R et al (2002). Regulation of human osteocalcin
promoter in hormone-independent human prostate cancer cells. J Biol Chem 277: 2468–2476.
115. David S. Morris1,2Integrating Biomedical Knowledge to Model Pathways of Prostate Cancer Progression[Cell
Cycle 6:10, 1177-1187, 15 May 2007]; ©2007 Landes Bioscience
116. WAEL A. SAKR, AND ALAN W. PARTINHISTOLOGICAL MARKERS OF RISK AND THE ROLE OF HIGH-GRADE PROSTATIC
INTRAEPITHELIAL NEOPLASIAUROLOGY 57 (Suppl 4A): 115–120, 2001. © 2001, Elsevier Science Inc.
117. THOMAS A. STAMEY,* JANET A. MOLECULAR GENETIC PROFILING OF GLEASON GRADE 4/5 PROSTATE CANCERS
COMPARED TO BENIGN PROSTATIC HYPERPLASIA0022-5347/01/1666-2171/0 THE JOURNAL OF UROLOGY® Vol.
166, 2171–2177, December 2001 Copyright © 2001 by AMERICAN UROLOGICAL ASSOCIATION, INC.® Printed in
U.S.A.
118. Dutton A, Lopez V, Murray PG, (2003) – Laser capture microdissection: Techniques and applications in the
molecular analysis of the cancer cell. Molecular Biology in Celullar Pathology Ed. John Wiley & Sons, p.213-231.
119. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA, Liotta LA, (1996) - Laser
capture microdissection. Science 274: 998–1001.
120. Elisabeta Jaba, Statistica, Editura Economica, 2002, Bucuresti
121. Elisabeta Jaba, Ana Grama, Analiza statistica cu SPSS sub Windows, Editura Polirom,2004
122. Ciucu G. Craiu V., Introducere in teoria probabilitatilor si statistica matematica, Ed. Didactica si Pedagogica,
Bucuresti1, 971
123. Narcisa Teodorescu., Probabilităţi şi statistică matematică cu Maple, Editura Bren, Bucureşti, 2006
124. Nossiter J., Utilizare Microsoft Excel, Editura Teora, 1998
125. Bolton S.,Pharmaceutical Statistics, 1990
126. Preda V., Teoria deciziilor statistice, Ed. Academiei Romane, Bucuresti, 1992
127. Vazquez Ortega Leopoldo et al., Diagnostic validity of prostate antigen density in prostate cancer
detection , Rev Mex Urol 2008; 68(4):203-206
128. J.A.Spencer, W.J.Chng, E.Hudson, A.P.Boon, P.Whelan, Prosatae specific antigen level and Gleason score in
predicting the stage of newly diagnosed prostate cancer, The British Journal of Radiology 71(1998), 1330-1135.
129. Collette Lawrence, Prostate-Specific Antigen (PSA) as a Surrogate End Point for Survival in Prostate Cancer
Clinical Trials, European urology 53 ( 2 0 0 8 ) 6–9
62